138 related articles for article (PubMed ID: 16782214)
1. Neuromedin U stimulates contraction of human long saphenous vein and gastrointestinal smooth muscle in vitro.
Jones NA; Morton MF; Prendergast CE; Powell GL; Shankley NP; Hollingsworth SJ
Regul Pept; 2006 Sep; 136(1-3):109-16. PubMed ID: 16782214
[TBL] [Abstract][Full Text] [Related]
2. Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system.
Mitchell JD; Maguire JJ; Kuc RE; Davenport AP
Cardiovasc Res; 2009 Feb; 81(2):353-61. PubMed ID: 18987052
[TBL] [Abstract][Full Text] [Related]
3. Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice.
Prendergast CE; Morton MF; Figueroa KW; Wu X; Shankley NP
Br J Pharmacol; 2006 Apr; 147(8):886-96. PubMed ID: 16474416
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical behavior of neuromedin U in isolated smooth muscle cells and intact tissue.
Brighton PJ; Wise A; Dass NB; Willars GB
J Pharmacol Exp Ther; 2008 Apr; 325(1):154-64. PubMed ID: 18180374
[TBL] [Abstract][Full Text] [Related]
5. Neuromedin U and its receptors: structure, function, and physiological roles.
Brighton PJ; Szekeres PG; Willars GB
Pharmacol Rev; 2004 Jun; 56(2):231-48. PubMed ID: 15169928
[TBL] [Abstract][Full Text] [Related]
6. Neuromedin U can exert colon-specific, enteric nerve-mediated prokinetic activity, via a pathway involving NMU1 receptor activation.
Dass NB; Bassil AK; North-Laidler VJ; Morrow R; Aziz E; Tuladhar BR; Sanger GJ
Br J Pharmacol; 2007 Feb; 150(4):502-8. PubMed ID: 17211455
[TBL] [Abstract][Full Text] [Related]
7. Heterologous expression and comparative characterization of the human neuromedin U subtype II receptor using the methylotrophic yeast Pichia pastoris and mammalian cells.
Shukla AK; Haase W; Reinhart C; Michel H
Int J Biochem Cell Biol; 2007; 39(5):931-42. PubMed ID: 17445746
[TBL] [Abstract][Full Text] [Related]
8. Neuromedin U: physiology, pharmacology and therapeutic potential.
Budhiraja S; Chugh A
Fundam Clin Pharmacol; 2009 Apr; 23(2):149-57. PubMed ID: 19645813
[TBL] [Abstract][Full Text] [Related]
9. Characterization of neuromedin U effects in canine smooth muscle.
Westfall TD; McCafferty GP; Pullen M; Gruver S; Sulpizio AC; Aiyar VN; Disa J; Contino LC; Mannan IJ; Hieble JP
J Pharmacol Exp Ther; 2002 Jun; 301(3):987-92. PubMed ID: 12023529
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a novel vasospastic transmitter system, neuromedin U, in the equine digital circulation.
Mitchell JD; Kuc RE; Maguire JJ; Davenport AP
Vet J; 2010 Oct; 186(1):106-9. PubMed ID: 19683464
[TBL] [Abstract][Full Text] [Related]
11. Identification of receptors for neuromedin U and its role in feeding.
Howard AD; Wang R; Pong SS; Mellin TN; Strack A; Guan XM; Zeng Z; Williams DL; Feighner SD; Nunes CN; Murphy B; Stair JN; Yu H; Jiang Q; Clements MK; Tan CP; McKee KK; Hreniuk DL; McDonald TP; Lynch KR; Evans JF; Austin CP; Caskey CT; Van der Ploeg LH; Liu Q
Nature; 2000 Jul; 406(6791):70-4. PubMed ID: 10894543
[TBL] [Abstract][Full Text] [Related]
12. Endogenous neuromedin U has anorectic effects in the Japanese quail.
Shousha S; Nakahara K; Miyazato M; Kangawa K; Murakami N
Gen Comp Endocrinol; 2005 Feb; 140(3):156-63. PubMed ID: 15639143
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterisation of four cDNAs encoding neuromedin U (NMU) from the brain and gut of goldfish, and the inhibitory effect of a deduced NMU on food intake and locomotor activity.
Maruyama K; Konno N; Ishiguro K; Wakasugi T; Uchiyama M; Shioda S; Matsuda K
J Neuroendocrinol; 2008 Jan; 20(1):71-8. PubMed ID: 18081554
[TBL] [Abstract][Full Text] [Related]
14. Proteinase-activated receptor-1 (PAR(1)) and PAR(2) but not PAR(4) mediate contraction in human and guinea-pig gallbladders.
Lee MC; Huang SC
Neurogastroenterol Motil; 2008 Apr; 20(4):385-91. PubMed ID: 18179608
[TBL] [Abstract][Full Text] [Related]
15. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3).
Kojima M; Haruno R; Nakazato M; Date Y; Murakami N; Hanada R; Matsuo H; Kangawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):435-8. PubMed ID: 11027493
[TBL] [Abstract][Full Text] [Related]
16. The motor effect of neuromedin U on rat stomach in vitro.
Benito-Orfila MA; Domin J; Nandha KA; Bloom SR
Eur J Pharmacol; 1991 Feb; 193(3):329-33. PubMed ID: 2055247
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of neuromedin U. IV. Absolute requirement of the arginine residue at position 7 of dog neuromedin U-8 for contractile activity.
Sakura N; Kurosawa K; Hashimoto T
Chem Pharm Bull (Tokyo); 2000 Aug; 48(8):1166-70. PubMed ID: 10959581
[TBL] [Abstract][Full Text] [Related]
18. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of rat neuromedin U for smooth muscle contraction.
Sakura N; Ohta S; Uchida Y; Kurosawa K; Okimura K; Hashimoto T
Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2016-20. PubMed ID: 1797423
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of neuromedin U. I. Contractile activity of dog neuromedin U-related peptides on isolated chicken crop smooth muscle.
Sakura N; Kurosawa K; Hashimoto T
Chem Pharm Bull (Tokyo); 1995 Jul; 43(7):1148-53. PubMed ID: 7586058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
